Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose)

Authors: Alsheikh-Ali A.A.; Abourjaily H.M.; Karas R.H.1

Source: The American Journal of Cardiology, Volume 89, Number 11, 1 June 2002 , pp. 1308-1310(3)

Publisher: Elsevier

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Language: English

Document Type: Short communication

DOI: 10.1016/S0002-9149(02)02334-2

Affiliations: 1: 1Dr. Karas has been a paid consultant or member of the speaker's bureau for Merck and Co., Whitehouse Station, New Jersey, and Pfizer, New York, New York.Department of Medicine, Division of Cardiology, Preventive Cardiology Center, , Boston, Massa

This article is hosted on another website.

You may be required to register, activate a subscription or purchase the article before you can obtain the full text.

Proceed

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A